ArticleOdontology2026
Calcitonin promotes osteogenic differentiation through CREB-mediated transcriptional upregulation of osteopontin in human periodontal ligament stem cells.
Article in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Osteogenic differentiation of human periodontal ligament stem cells (PDLSCs) facilitates the neogenesis of alveolar bone and contribute to the alveolar bone repair. Calcitonin (CT) has been reported to promote osteogenic differentiation in osteoblast, but its effects and mechanism on human PDLSCs remain obscure. In this study, alizarin red staining and western blot were used to evaluate the osteogenic differentiation and the expression level of cAMP-response element-binding protein (CREB), phosphorylated CREB (pCREB), and osteopontin (OPN) in human PDLSCs. The transcriptional regulation of CREB on OPN expression was detected by chromatin immunoprecipitation (ChIP) and luciferase reporter assays. In human PDLSCs, CT overexpression significantly enhanced the expression of OPN and strengthened the mineralization, and upregulated the expression level of CREB and pCREB. The mineralized deposit and expression of OPN promoted by CT were reduced by inhibiting the expression or activity of CREB. CREB could directly bind to OPN promoter and transcriptionally regulate OPN expression. Inhibiting the expression of OPN reversed the cell osteogenic differentiation promoted by CREB. Our study supports that CT can promote osteogenic differentiation of human PDLSCs through enhancing the expression and phosphorylation of CREB, subsequently transcriptionally regulating OPN expressions.
Indexed as
Identifiers
40794355What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.